FDA cosmetics

February monthly roundup

EU Prostaglandin Analogues: Final Opinion of the SCCS The Scientific Committee on Consumer Safety (SCCS) has published the final Opinion on prostaglandin analogues used in cosmetic products (notably lash and brow serums) on 10 February 2026. In 2022, SCCS was unable to conclude on safety due to insufficient data. Following new industry submissions, the Committee has now […]

February monthly roundup Read More »

January monthly roundup

EU Omnibus Act VIII: new CMR bans and restrictions published The European Union has formally published Regulation (EU) 2026/78, the eighth annual “CMR Omnibus” regulation amending the EU Cosmetics Regulation. The text transposes the 22nd ATP of the CLP Regulation into cosmetic law and introduces extensive changes to Annexes II, III, IV and V. Key regulatory changes include: Timeline

January monthly roundup Read More »

December monthly roundup

EU Titanium Dioxide: EU Formally Confirms End of Carcinogenic Classification On 10 December 2025, the European Commission confirmed in the Official Journal the annulment of the harmonised Carcinogen Category 2 classification for titanium dioxide (TiO₂) under the CLP Regulation. This follows the Court of Justice of the European Union (CJEU) decision of 1 August 2025, which upheld the annulment of part of Delegated Regulation (EU) 2020/217. As a

December monthly roundup Read More »

September regulatory roundup

EU News EU Issues Draft Regulation on Cosmetic Ingredients: New Classifications May Lead to Restrictions On 25 September 2024, the European Union issued a draft Regulation representing the 23rd Adaptation to Technical and Scientific Progress (ATP) under the Classification, Labelling, and Packaging (CLP) Regulation. This draft focuses on classifying eight chemical substances, several of which are widely used in cosmetics and other sectors.

September regulatory roundup Read More »

Cosmetics Direct FDA Portal for Cosmetic Product Listing is Live

The U.S. Food and Drug Administration (FDA) has launched Cosmetics Direct on 18 December! Cosmetics Direct is an electronic portal for registering and listing cosmetic product facilities and products. This initiative, mandated by the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), aims to streamline the submission process for the industry. Cosmetics Direct provides a

Cosmetics Direct FDA Portal for Cosmetic Product Listing is Live Read More »

FDA’s New Reporting Standards for Cosmetic Adverse Events

The FDA has announced significant updates for reporting severe adverse events in cosmetics, as required by the 2022 Modernization of Cosmetics Regulation Act (MoCRA). These important changes, affecting manufacturers, packers, and distributors, will become enforceable on December 29, 2023. Key points of the FDA’s update include: This update signifies a significant step in ensuring consumer

FDA’s New Reporting Standards for Cosmetic Adverse Events Read More »

Major Updates in Cosmetic Regulations USA: What You Need to Know

The Modernization of Cosmetic Regulations Act of 2022 (MoCRA) Brings Significant Changes In a landmark move to ensure consumer safety, the Modernization of Cosmetic Regulations Act of 2022 (MoCRA) has introduced pivotal changes to the cosmetic industry’s regulatory framework. These modifications, effective from December 29, are a result of amendments to Chapter VI of the

Major Updates in Cosmetic Regulations USA: What You Need to Know Read More »

FDA Delays Enforcement of Cosmetic Registration Requirements: What You Need to Know

The U.S. Food and Drug Administration (FDA) has recently made an important announcement that will have a significant impact on the cosmetic industry. In a move aimed at providing the industry with additional time to meet compliance requirements, the FDA has decided to delay the enforcement of the cosmetic product facility registration and product listing

FDA Delays Enforcement of Cosmetic Registration Requirements: What You Need to Know Read More »

MoCRA – which businesses qualify for exemption?

MoCRA (Sec. 612) exempts certain small businesses from GMP, facility registration and product listing. Small businesses are defined as businesses with average gross annual sales of cosmetic products in the USA for the previous 3-year period of less than $1,000,000 (adjusted for inflation). However, this exemption does not apply to facilities producing cosmetic products that:

MoCRA – which businesses qualify for exemption? Read More »

What you need to know when making cosmetic claims in the USA

Cosmetic claims represent an important part of cosmetic product labelling. They are a great marketing tool as they persuade consumers into choosing a certain product from a sea of many similar products. Therefore, it is crucial that the beauty brands use claims that are honest, truthful, sufficiently substantiated and appropriate for cosmetic products. Different countries

What you need to know when making cosmetic claims in the USA Read More »